Search

Your search keyword '"Herbelin, Laura"' showing total 226 results

Search Constraints

Start Over You searched for: Author "Herbelin, Laura" Remove constraint Author: "Herbelin, Laura"
226 results on '"Herbelin, Laura"'

Search Results

3. Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial

4. Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial

5. Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial

6. A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.

7. Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

8. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

9. Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial

10. Database Evaluation for Muscle and Nerve Diseases - DEMAND: An academic neuromuscular coding system

11. Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study

15. Episodic Ataxia Type 1: Natural History and Effect on Quality of Life.

18. A Randomized, Double-Blind, Placebo-Controlled Study of Arimoclomol in Patients with Inclusion Body Myositis (S23.010)

22. Safety of aerobic exercise in people with diabetic peripheral neuropathy: single-group clinical trial

23. Phase II Study of Arimoclomol in IBM FDA-OOPD

24. Abstracts from the ASENT 2008 Annual Meeting March 6–8, 2008

25. Books to Read Before You Graduate High School

30. A quantitative measure of handgrip myotonia in non-dystrophic myotonia

34. Amyloid Myopathy as an Inclusion Body Myositis Mimic

35. Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS

38. Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy

39. CLINICAL FINDINGS IN MUSK-ANTIBODY POSITIVE MYASTHENIA GRAVIS: A U.S. EXPERIENCE

41. Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

44. Rasagiline for Amyotrophic Lateral Sclerosis: a Randomized Controlled Trial

45. Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

46. Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysis

47. 2269-PUB: Early Attrition from a Randomized Lifestyle Modification Protocol

48. Subcutaneous Immunoglobulin in Myasthenia Gravis: Results of a North American Open Label Study (N4.002)

49. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Catalog

Books, media, physical & digital resources